Rita Ojeil
Biographic Data
| ID | 9993083 |
|---|---|
| NAME | Rita Ojeil |
| GIVEN NAMES | Rita |
| FAMILY NAME | Ojeil |
| SIGNATURE | OJEIL R |
| AFFILIATIONS | R2M Solution (Italy) |
| ORCID | 0000-0001-8078-5597 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Shifting sands in Saudi Arabian healthcare system towards value-based care
The KSA’s healthcare system is undergoing substantial transformation under Vision 2030, with a strategic shift toward value-based healthcare (VBHC). This perspective paper examines the national reform initiatives and implementation readiness using five interrelated domains: data interoperability and governance, health technology assessment (HTA) capacity and availability of local data, policy fragmentation across high-cost therapeutic areas, oper…
Driving the future of value-based healthcare in the Gulf Cooperation Council
Gulf Cooperation Council (GCC) countries are undergoing a critical transformation in their healthcare systems. This empowers them to address the rising burden of complex diseases, including rare diseases, cancer, neurological disorders, and immunological illnesses, which involve a high cost of therapy. A strategic shift from volume- to value-based healthcare (VBH) emphasizes sustainability, enhanced accessibility, and improved health outcomes thr…
Balancing innovation and affordability in relapsing-remitting multiple sclerosis
Introduction: Relapsing-Remitting Multiple Sclerosis (RRMS) is the most prevalent form of multiple sclerosis, characterized by episodic neurological deterioration and recovery. The rising burden of RRMS in Saudi Arabia, underscores the need for cost-effective treatment strategies. This study evaluates the economic impact of disease-modifying therapies (DMTs) for RRMS from a national healthcare payer perspective, with a focus on the role of manage…
No prominent works on this page.
Driving the future of value-based healthcare in the Gulf Cooperation Council
Gulf Cooperation Council (GCC) countries are undergoing a critical transformation in their healthcare systems. This empowers them to address the rising burden of complex diseases, including rare diseases, cancer, neurological disorders, and immunological illnesses, which involve a high cost of therapy. A strategic shift from volume- to value-based healthcare (VBH) emphasizes sustainability, enhanced accessibility, and improved health outcomes thr…
Balancing innovation and affordability in relapsing-remitting multiple sclerosis
Introduction: Relapsing-Remitting Multiple Sclerosis (RRMS) is the most prevalent form of multiple sclerosis, characterized by episodic neurological deterioration and recovery. The rising burden of RRMS in Saudi Arabia, underscores the need for cost-effective treatment strategies. This study evaluates the economic impact of disease-modifying therapies (DMTs) for RRMS from a national healthcare payer perspective, with a focus on the role of manage…
Shifting sands in Saudi Arabian healthcare system towards value-based care
The KSA’s healthcare system is undergoing substantial transformation under Vision 2030, with a strategic shift toward value-based healthcare (VBHC). This perspective paper examines the national reform initiatives and implementation readiness using five interrelated domains: data interoperability and governance, health technology assessment (HTA) capacity and availability of local data, policy fragmentation across high-cost therapeutic areas, oper…
Health Systems, Economic Evaluations, Quality of Life (3 works) · Reimbursement (3 works) · Health care (2 works) · Health technology (2 works) · Pharmaceutical Economics and Policy (2 works) · Economic impact analysis (1 work) · Exploratory analysis (1 work) · Exploratory research (1 work) · Formulary (1 work) · Genomics and Rare Diseases (1 work)